CVS
Income statement / Annual
Last year (2024), CVS Health Corporation's total revenue was $372.81 B,
an increase of 4.20% from the previous year.
In 2024, CVS Health Corporation's net income was $4.61 B.
See CVS Health Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$372.81 B |
$357.78 B |
$322.47 B |
$292.11 B |
$268.71 B |
$256.78 B |
$194.58 B |
$184.79 B |
$177.55 B |
$153.29 B |
| Cost of Revenue |
$321.41 B
|
$303.35 B
|
$267.97 B
|
$239.99 B
|
$219.66 B
|
$211.25 B
|
$163.04 B
|
$156.26 B
|
$148.71 B
|
$126.76 B
|
| Gross Profit |
$51.40 B
|
$54.43 B
|
$54.50 B
|
$52.12 B
|
$49.05 B
|
$45.53 B
|
$31.54 B
|
$28.53 B
|
$28.83 B
|
$26.53 B
|
| Gross Profit Ratio |
0.14
|
0.15
|
0.17
|
0.18
|
0.18
|
0.18
|
0.16
|
0.15
|
0.16
|
0.17
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
-$1.28 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Other Expenses |
$42.89 B
|
$40.69 B
|
$46.55 B
|
$38.81 B
|
$35.14 B
|
$33.54 B
|
$27.52 B
|
$18.99 B
|
$18.45 B
|
$17.05 B
|
| Operating Expenses |
$41.61 B
|
$40.69 B
|
$46.55 B
|
$38.81 B
|
$35.14 B
|
$33.54 B
|
$27.52 B
|
$18.99 B
|
$18.45 B
|
$17.05 B
|
| Cost And Expenses |
$363.01 B
|
$344.03 B
|
$314.51 B
|
$278.80 B
|
$254.80 B
|
$244.79 B
|
$190.56 B
|
$175.25 B
|
$167.16 B
|
$143.82 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$21.00 M
|
$20.00 M
|
$21.00 M
|
| Interest Expense |
$2.96 B
|
$2.66 B
|
$2.29 B
|
$2.50 B
|
$2.91 B
|
$3.04 B
|
$2.62 B
|
$1.06 B
|
$1.08 B
|
$859.00 M
|
| Depreciation & Amortization |
$4.60 B
|
$4.37 B
|
$4.22 B
|
$4.49 B
|
$4.44 B
|
$4.37 B
|
$2.72 B
|
$2.48 B
|
$2.48 B
|
$2.09 B
|
| EBITDA |
$13.70 B |
$18.20 B |
$12.35 B |
$17.53 B |
$17.12 B |
$16.40 B |
$6.74 B |
$11.81 B |
$12.19 B |
$11.57 B |
| EBITDA Ratio |
0.04
|
0.05
|
0.06
|
0.07
|
0.07
|
0.06
|
0.07
|
0.06
|
0.08
|
0.08
|
| Operating Income Ratio |
0.02
|
0.04
|
0.05
|
0.05
|
0.05
|
0.05
|
0.02
|
0.05
|
0.06
|
0.06
|
| Total Other Income/Expenses Net |
-$2.37 B
|
-$2.57 B
|
-$2.12 B
|
-$2.77 B
|
-$4.14 B
|
-$2.99 B
|
-$2.62 B
|
-$1.27 B
|
-$1.75 B
|
-$859.00 M
|
| Income Before Tax |
$6.15 B
|
$11.17 B
|
$5.84 B
|
$10.54 B
|
$9.77 B
|
$9.00 B
|
$1.41 B
|
$8.27 B
|
$8.64 B
|
$8.62 B
|
| Income Before Tax Ratio |
0.02
|
0.03
|
0.02
|
0.04
|
0.04
|
0.04
|
0.01
|
0.04
|
0.05
|
0.06
|
| Income Tax Expense |
$1.56 B
|
$2.81 B
|
$1.51 B
|
$2.55 B
|
$2.57 B
|
$2.37 B
|
$2.00 B
|
$1.64 B
|
$3.32 B
|
$3.39 B
|
| Net Income |
$4.61 B
|
$8.34 B
|
$4.31 B
|
$8.00 B
|
$7.18 B
|
$6.63 B
|
-$594.00 M
|
$6.62 B
|
$5.32 B
|
$5.24 B
|
| Net Income Ratio |
0.01
|
0.02
|
0.01
|
0.03
|
0.03
|
0.03
|
-0
|
0.04
|
0.03
|
0.03
|
| EPS |
3.66 |
6.49 |
3.29 |
6 |
5.48 |
5.1 |
-0.57 |
6.47 |
4.93 |
4.66 |
| EPS Diluted |
3.66 |
6.47 |
3.26 |
5.95 |
5.46 |
5.08 |
-0.57 |
6.44 |
4.9 |
4.63 |
| Weighted Average Shares Out |
$1.26 B
|
$1.29 B
|
$1.31 B
|
$1.32 B
|
$1.31 B
|
$1.30 B
|
$1.04 B
|
$1.02 B
|
$1.07 B
|
$1.12 B
|
| Weighted Average Shares Out Diluted |
$1.26 B
|
$1.29 B
|
$1.32 B
|
$1.33 B
|
$1.31 B
|
$1.31 B
|
$1.04 B
|
$1.02 B
|
$1.08 B
|
$1.13 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
